Status:
ACTIVE_NOT_RECRUITING
Alpha and Omega of Lifestyle Therapy
Lead Sponsor:
Inland Norway University of Applied Sciences
Conditions:
Obesity
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The study aims to investigate the effects of double-blinded, randomized placebo-controlled n3-fatty acid supplementation (1000 mg day-1) and 13 weeks of resistance training on muscle function/biology ...
Detailed Description
Lifestyle therapy is important for treating lifestyle-related morbidities such as obesity. Such therapy often includes exercise and nutrition, and leads to improved health, functionality and quality o...
Eligibility Criteria
Inclusion
- Untrained (less than 2 sessions of resistance exercise per month and less than 3 hours of endurance exercise per week)
Exclusion
- Unstable cardiovascular disease
- Injuries affecting the ability to perform heavy resistance exercise
- Mental illness
- Allergy to local anesthesia
- Smoking
- Use of medicine or drugs containing steroids the last two months prior to inclusion
Key Trial Info
Start Date :
September 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04279951
Start Date
September 2 2019
End Date
December 1 2026
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inland Norway University of Applied Sciences
Lillehammer, Norway